PROCRASTINAGER
LIVE

Serial Number

98314329

Owner

Thomas C. West

Attorney

Ralph P. Albrecht

Filing Date

Dec 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PROCRASTINAGER Trademark

Serial Number: 98314329

PROCRASTINAGER is a trademark filed by Thomas C. West on December 14, 2023. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Thomas C. West (2 trademarks)

302 N Cherry Street
Falls Church, VA 22046

Entity Type: 01

Trademark Details

Filing Date

December 14, 2023

Registration Date

Not Registered

Published for Opposition

August 27, 2024

Goods & Services

Consulting services in the field of the diagnosis and treatment of psychological conditions, aging-related conditions and diseases being Alzheimer's, Parkinson's, cardiovascular, heart, hypertension, Type 2 diabetes, chronic obstructive pulmonary disease (COPD), cancer, stroke, osteoarthritis, rheumatoid arthritis, chronic kidney disease, age-related macular generation, cataracts, glaucoma, peripheral artery disease, hyper lipidemia or high cholesterol, hearing loss, vision impairment, cognitive decline, cognitive impairment, osteoporosis, joint pain and stiffness, arthritis, loss of muscle mass, sarcopenia, increased susceptibility to falls, balance issues, coordination issues, sleep disorders, skin changes, thinning, or loss of elasticity, dental issues, tooth loss, gum disease, urinary incontinence, reduced mobility or dexterity, digestive issues, constipation, or slower metabolism, and changes in taste and smell, and longevity-related conditions and diseases being Alzheimer's, Parkinson's, cardiovascular, heart, hypertension, Type 2 diabetes, chronic obstructive pulmonary disease (COPD), cancer, stroke, osteoarthritis, rheumatoid arthritis, chronic kidney disease, age-related macular generation, cataracts, glaucoma, peripheral artery disease, hyper lipidemia or high cholesterol, hearing loss, vision impairment, cognitive decline, cognitive impairment, osteoporosis, joint pain and stiffness, arthritis, loss of muscle mass, sarcopenia, increased susceptibility to falls, balance issues, coordination issues, sleep disorders, skin changes, thinning, or loss of elasticity, dental issues, tooth loss, gum disease, urinary incontinence, reduced mobility or dexterity, digestive issues, constipation, or slower metabolism, and changes in taste and smell; Psychological consultation; Psychological consultations; Psychological counseling

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 22, 2026 EX3G
SOU EXTENSION 3 FILED
Apr 21, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 21, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 13, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 13, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 13, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 17, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 17, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 16, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 16, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 22, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 17, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 15, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 15, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 15, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2024 NWOS
NEW APPLICATION ENTERED
Dec 14, 2023 NWAP